SCHEMBL2926382

SCHEMBL2926382

F[C]1CC=Cc2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
BCHE P06276 1/20 0.35
POLB P06746 1/20 0.35
PTPRC P08575 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
IDO1 P14902 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
PTPN1 P18031 1/20 0.35
ACHE P22303 1/20 0.35
CES1 P23141 1/20 0.35
RECQL P46063 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2926757 0.77 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL7214854 0.76 ALDH1A1 (0.38) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL21385218 0.75 CYP1A2 (0.34) ALDH1A1HSD17B10HPGDTP53CYP1A2
SCHEMBL2324920 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL1941287 0.73 ALDH1A1 (0.40) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL29211531 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL219752 0.73 TSHR (0.36) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL5894113 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL29569948 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL29422894 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060159953-A1 Diarylamino substituted arylvinyl naphthalene compounds and a blue-light electroluminescent device having the compounds LABELTEK INC. 2006-07-20 US claimed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 EP disclosed
CN-117616032-A Rare earth complex 东曹株式会社 2024-02-27 CN disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 WO disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 US disclosed
WO-2019181954-A1 POLYMERIZABLE COMPOUND, PHOTOCURABLE POLYMER, INSULATING FILM, PROTECTIVE FILM, AND ORGANIC TRANSISTOR DEVICE 東ソー株式会社 2019-09-26 WO disclosed
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2016-11-24 US disclosed
EP-1892242-B1 Method of purifying 3-phenyl-3,4-epoxy-2-butanol derivatives by liquid-liquid extraction SUMITOMO CHEMICAL CO (JP) 2010-09-29 EP disclosed
US-7459573-B2 Method of purifying epoxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-12-02 US disclosed
US-20080081921-A1 Method of purifying epoxy compound SUMITOMO CHEMICAL COMPANY, LIMITED 2008-04-03 US disclosed
EP-1892242-A1 Method of purifying 3-phenyl-3,4-epoxy-2-butanol derivatives by liquid-liquid extraction Sumitomo Chemical Company, Limited (JP) 2008-02-27 EP disclosed
US-20060159953-A1 Diarylamino substituted arylvinyl naphthalene compounds and a blue-light electroluminescent device having the compounds LABELTEK INC. 2006-07-20 US disclosed
US-20060159953-A1 Diarylamino substituted arylvinyl naphthalene compounds and a blue-light electroluminescent device having the compounds LABELTEK INC. 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060159953-A1 Diarylamino substituted arylvinyl naphthalene compounds and a blue-light electroluminescent device having the compounds AHR, ARNT, ARL1 ALDH1A1 186/4885HSD17B10 1708/4885MEN1 1720/4885
US-20080081921-A1 Method of purifying epoxy compound RER1, ELP1, AQP1 ALDH1A1 297/4885HSD17B10 1208/4885MEN1 2962/4885
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 ALDH1A1 151/4885HSD17B10 339/4885MEN1 4766/4885
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL CBR1, HAO2, CBR3 ALDH1A1 151/4885HSD17B10 339/4885MEN1 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.